Over a period of @ weeks , the improvement ( reduction ) in mean scores on the IRLS scale was greater , by @ points , among participants receiving pregabalin than among those receiving placebo ( P < @ ) , and the proportion of patients with symptoms that were very much improved or much improved was also greater with pregabalin than with placebo ( @ % vs. @ % , P < @ ) .